<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0020125"><a href="http://purl.obolibrary.org/obo/MONDO_0020125">MONDO:0020125</a></h3>
<p><strong>Label:</strong> acquired neuromuscular junction disease</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0018743">MONDO:0018743</a> (immune-mediated acquired neuromuscular junction disease), <a href="http://purl.obolibrary.org/obo/MONDO_0009688">MONDO:0009688</a> (myasthenia gravis), <a href="http://purl.obolibrary.org/obo/MONDO_0016468">MONDO:0016468</a> (toxin-mediated infectious botulism), <a href="http://purl.obolibrary.org/obo/MONDO_0015805">MONDO:0015805</a> (intestinal botulism), <a href="http://purl.obolibrary.org/obo/MONDO_0005498">MONDO:0005498</a> (botulism),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_1267">Orphanet:1267</a>, <a href="http://purl.obolibrary.org/obo/OMIM_159400">OMIM:159400</a>, <a href="http://www.orpha.net/ORDO/Orphanet_178481">Orphanet:178481</a>, <a href="http://purl.obolibrary.org/obo/OMIM_607085">OMIM:607085</a>, <a href="http://www.orpha.net/ORDO/Orphanet_464764">Orphanet:464764</a>, <a href="http://purl.obolibrary.org/obo/OMIM_254200">OMIM:254200</a>, <a href="http://www.orpha.net/ORDO/Orphanet_230800">Orphanet:230800</a>, <a href="http://www.orpha.net/ORDO/Orphanet_589">Orphanet:589</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0010978">HP:0010978</a> (Abnormality of immune system physiology) and <a href="http://purl.obolibrary.org/obo/HP_0030191">HP:0030191</a> (Abnormal peripheral nervous system synaptic transmission) and <a href="http://purl.obolibrary.org/obo/HP_0100522">HP:0100522</a> (Thymoma) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010978">HP:0010978</a> (Abnormality of immune system physiology) and <a href="http://purl.obolibrary.org/obo/HP_0012535">HP:0012535</a> (Abnormal synaptic transmission) and <a href="http://purl.obolibrary.org/obo/HP_0100522">HP:0100522</a> (Thymoma) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0010978">HP:0010978</a> (Abnormality of immune system physiology) and <a href="http://purl.obolibrary.org/obo/HP_0012373">HP:0012373</a> (Abnormal eye physiology) and <a href="http://purl.obolibrary.org/obo/HP_0100522">HP:0100522</a> (Thymoma) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003473">HP:0003473</a> (Fatigable weakness) and <a href="http://purl.obolibrary.org/obo/HP_0010978">HP:0010978</a> (Abnormality of immune system physiology) and <a href="http://purl.obolibrary.org/obo/HP_0100522">HP:0100522</a> (Thymoma) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003398">HP:0003398</a> (Abnormal synaptic transmission at the neuromuscular junction) and <a href="http://purl.obolibrary.org/obo/HP_0010978">HP:0010978</a> (Abnormality of immune system physiology) and <a href="http://purl.obolibrary.org/obo/HP_0100522">HP:0100522</a> (Thymoma) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002960">HP:0002960</a> (Autoimmunity) and <a href="http://purl.obolibrary.org/obo/HP_0030191">HP:0030191</a> (Abnormal peripheral nervous system synaptic transmission) and <a href="http://purl.obolibrary.org/obo/HP_0100522">HP:0100522</a> (Thymoma) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002960">HP:0002960</a> (Autoimmunity) and <a href="http://purl.obolibrary.org/obo/HP_0012535">HP:0012535</a> (Abnormal synaptic transmission) and <a href="http://purl.obolibrary.org/obo/HP_0100522">HP:0100522</a> (Thymoma) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002960">HP:0002960</a> (Autoimmunity) and <a href="http://purl.obolibrary.org/obo/HP_0012373">HP:0012373</a> (Abnormal eye physiology) and <a href="http://purl.obolibrary.org/obo/HP_0100522">HP:0100522</a> (Thymoma) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002960">HP:0002960</a> (Autoimmunity) and <a href="http://purl.obolibrary.org/obo/HP_0003473">HP:0003473</a> (Fatigable weakness) and <a href="http://purl.obolibrary.org/obo/HP_0100522">HP:0100522</a> (Thymoma) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002960">HP:0002960</a> (Autoimmunity) and <a href="http://purl.obolibrary.org/obo/HP_0003398">HP:0003398</a> (Abnormal synaptic transmission at the neuromuscular junction) and <a href="http://purl.obolibrary.org/obo/HP_0100522">HP:0100522</a> (Thymoma) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000508">HP:0000508</a> (Ptosis) and <a href="http://purl.obolibrary.org/obo/HP_0010978">HP:0010978</a> (Abnormality of immune system physiology) and <a href="http://purl.obolibrary.org/obo/HP_0100522">HP:0100522</a> (Thymoma) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000508">HP:0000508</a> (Ptosis) and <a href="http://purl.obolibrary.org/obo/HP_0002960">HP:0002960</a> (Autoimmunity) and <a href="http://purl.obolibrary.org/obo/HP_0100522">HP:0100522</a> (Thymoma) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000478">HP:0000478</a> (Abnormality of the eye) and <a href="http://purl.obolibrary.org/obo/HP_0010978">HP:0010978</a> (Abnormality of immune system physiology) and <a href="http://purl.obolibrary.org/obo/HP_0100522">HP:0100522</a> (Thymoma) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000478">HP:0000478</a> (Abnormality of the eye) and <a href="http://purl.obolibrary.org/obo/HP_0002960">HP:0002960</a> (Autoimmunity) and <a href="http://purl.obolibrary.org/obo/HP_0100522">HP:0100522</a> (Thymoma) 62.50%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0030191">HP:0030191</a> (Abnormal peripheral nervous system synaptic transmission) and <a href="http://purl.obolibrary.org/obo/HP_0100522">HP:0100522</a> (Thymoma) 53.32%</li>
</ul>
</body>
</html>
